SCHEMBL21724501

SCHEMBL21724501

CCCCCCCCCCCCCC(=O)N[C@@H]([C]=O)CCC(=O)O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2C Q5R387 1/20 0.63
PLA2G10 O15496 2/20 0.58
FAAH O00519 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
MAPK1 P28482 1/20 0.53
NOD1 Q9Y239 1/20 0.51
HSP90AA1 P07900 1/20 0.49
GPR84 Q9NQS5 7/20 0.48
PPARG P37231 7/20 0.48
PPARD Q03181 7/20 0.48
PPARA Q07869 7/20 0.48
HDAC11 Q96DB2 5/20 0.48
TSHR P16473 4/20 0.48
PTPN1 P18031 3/20 0.48
ALDH1A1 P00352 2/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
SLC22A6 Q4U2R8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21724681 1.00 PLA2G2C (0.63) PLA2G2CPLA2G10FAAHMEN1KMT2A
SCHEMBL27960067 1.00 PLA2G2C (0.63) PLA2G2CPLA2G10FAAHMEN1KMT2A
SCHEMBL6041045 1.00 PLA2G2C (0.63) PLA2G2CPLA2G10FAAHMEN1KMT2A
SCHEMBL6041046 1.00 PLA2G2C (0.63) PLA2G2CPLA2G10FAAHMEN1KMT2A
SCHEMBL11024007 1.00 PLA2G2C (0.63) PLA2G2CPLA2G10FAAHMEN1KMT2A
SCHEMBL21724603 1.00 PLA2G2C (0.63) PLA2G2CPLA2G10FAAHMEN1KMT2A
SCHEMBL20876509 1.00 PLA2G2C (0.63) PLA2G2CPLA2G10FAAHMEN1KMT2A
SCHEMBL21724244 0.98 PLA2G2C (0.60) PLA2G2CPLA2G10FAAHMEN1KMT2A
SCHEMBL27889998 0.92 TERT (0.56) PLA2G2CFAAHKMT2APPARGPPARD
SCHEMBL25173449 0.90 PLA2G2C (0.49) PLA2G2CPLA2G10FAAHMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3836971-A1 CONJUGATES AND METHODS OF USING THE SAME Flagship Pioneering Innovations V, Inc. (US) 2021-06-23 EP claimed
US-20210162057-A1 CONJUGATES AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-06-03 US claimed
WO-2020037009-A1 CONJUGATES AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2020-02-20 WO claimed
US-11998610-B2 Conjugates and methods of using the same FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2024-06-04 US disclosed
EP-3836971-A1 CONJUGATES AND METHODS OF USING THE SAME Flagship Pioneering Innovations V, Inc. (US) 2021-06-23 EP disclosed
US-20210162057-A1 CONJUGATES AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-06-03 US disclosed
WO-2020037009-A1 CONJUGATES AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2020-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11998610-B2 Conjugates and methods of using the same CD47, CD44, CD74 PLA2G2C 999/4885PLA2G10 786/4885FAAH 2742/4885
US-20210162057-A1 CONJUGATES AND METHODS OF USING THE SAME CD47, CD44, CD74 PLA2G2C 999/4885PLA2G10 786/4885FAAH 2742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.